Form 8-K - Current report:
SEC Accession No. 0000950170-25-083180
Filing Date
2025-06-06
Accepted
2025-06-06 16:39:59
Documents
11
Period of Report
2025-06-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

Document Format Files

Seq Description Document Type Size
1 8-K bolt-20250606.htm   iXBRL 8-K 54405
2 EX-3.1 bolt-ex3_1.htm EX-3.1 14369
  Complete submission text file 0000950170-25-083180.txt   186924

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20250606.xsd EX-101.SCH 28196
13 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20250606_htm.xml XML 5121
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

EIN.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 251031322
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)